Status
Conditions
About
The goal of this observational study is to enroll diabetic patients with diabetic retinopathy and those without diabetic retinopathy, follow up and observe the long-term changes in ocular structure and function of the subjects by comparison, analyze their association with multimodal biomarkers, and explore new methods for the early diagnosis and risk prediction of diabetic retinopathy.
Participants will be followed up over a 5-year follow-up period, during which they will undergo ophthalmic examinations, blood tests, and questionnaires.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Participants must understand the clinical trial, voluntarily participate, and sign the informed consent form.
Aged 18-80 years, with no restriction on gender.
Healthy control group: No history or diagnosis of diabetes.
Diabetic group:
i) Definite diagnosis of diabetes. Both type 1 and type 2 diabetic patients will be included in this study.
ii) Based on dilated fundus examination, subjects are classified into NDR, NPDR, and PDR groups according to the staging of diabetic retinopathy.
Exclusion criteria
1,538 participants in 5 patient groups
Loading...
Central trial contact
Kangjie Kong, MD, PhD; Li Tao, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal